Anti-GD3 Monoclonal Antibody1vial

1-Ethyl-1H-tetrazol-5-amine, 95.0%, 1g

3-Bromo-4-oxo-piperidine-1-carboxylic acid benzyl ester, 95.0%, 5g

3-Bromo-2-hydroxybenzaldehyde, 95.0%, 10g

Tert-butyl phenyl(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)carbamate, 95+%, 250mg

1-(Methylamino)cyclopropane-1-carboxylic acid, 1g

4-BROMO-2-FLUORO-5-METHOXYBENZALDEHYDE, 95.0%, 100mg

3-Bromothietane 1,1-dioxide, 95.0%, 250mg

2-(2,5-dimethyl-1H-indol-3-yl)-N-(furan-2-ylmethyl)ethan-1-amine hydrochloride, 95.0%, 500mg

5-Methyl-pyrazine-2-carboxylic acid, 98.0%, 25g

tert-Butyl ((5-(aminomethyl)pyridin-2-yl)methyl)carbamate, 95%, 50mg

2-[(3-Morpholin-4-ylpropyl)amino]-5-nitrobenzonitrile, 95.0%, 250mg

(4-chloro-2-nitrophenoxy)acetic acid, 95.0%, 25g